![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Myopia, Degenerative - 15 Studies Found
Recruiting |
: Genomewide Screening of Pathological Myopia : Pathological Myopia : 2005-09-09 |
Recruiting |
: Early Vitrectomy for Macular Tractional Maculopathy : Myopia, Degenerative : 2010-04-30 : Procedure: Early vitrectomy Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine gree |
Completed |
: Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia : Myopia, Degenerative : 2013-07-10 :
|
Completed |
: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia :
: 2011-08-22 : Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/- |
Completed |
: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen : Choroidal Neovascularisation : 2009-12-21 : Drug: ranibizumab 0.5mg |
Completed |
: Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia : Pathological Myopia : 2010-10-06 :
|
Completed |
: A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV : Choroid Neovascularization Secondary to Degenerative Myopia : 2013-03-11 :
|
Completed |
: Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) :
: Drug: Bevacizumab |
Recruiting |
: Ocular Discomfort Assessment After Intravitreal Injections :
|
Recruiting |
: Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases :
|